European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Life Sciences & Pharma

Health Equity in Pharma: A Closer Look at Industry Progress

August 13, 2025

Life Sciences & Pharma

On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (South Korea)

August 12, 2025

MedTech

Hospital Priorities 2025 China Edition: Key Findings for Medtech and Pharma Companies

June 20, 2025

Executive Insights

Life Sciences & Pharma

Transitioning to EU-Wide Health Technology Assessments: Implications for Pharma

April 14, 2025

Healthcare Services

Bridge the Gap: Unlocking Innovative Medical Device Access in India via Evidence-based…

February 11, 2025

Executive Insights

Life Sciences & Pharma

Redefining Biopharma R&D Productivity: New Insights and Strategies

January 9, 2025